KYNTRA BIO, INC. (KYNB) Free cash flow 2016–2025
KYNTRA BIO, INC. (KYNB) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$4.8MFY2025 · since FY2016: $5.9M → -$4.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$4.8M | +96.5% |
| FY2024 | -$138.3M | +56.5% |
| FY2023 | -$317.5M | -112.2% |
| FY2022 | -$149.7M | -71.2% |
| FY2021 | -$87.4M | -212.6% |
| FY2020 | $77.6M | +191.9% |
| FY2019 | -$84.5M | -0.4% |
| FY2018 | -$84.2M | -12.2% |
| FY2017 | -$75.0M | -1381.0% |
| FY2016 | $5.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice